A Study to Evaluate the Long-term Safety, Tolerability and Efficacy of Bimekizumab in Patients With Chronic Plaque Psoriasis
Clinical trial NCT03010527 · COMPLETED
Trial details
- NCT number
- NCT03010527
- Sponsor
- UCB Biopharma SRL
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-14
- Primary completion
- 2018-09-25
- Enrollment
- 217
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.